Capital International Investors
CLVS

Capital International Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

Capital International Investors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-119,000
Closed -$803K – 450
2020
Q2 		$803K Hold
119,000
– – ﹤0.01% 404
2020
Q1 		$757K Hold
119,000
– – ﹤0.01% 384
2019
Q4 		$1.24M Hold
119,000
– – ﹤0.01% 379
2019
Q3 		$468K Hold
119,000
– – ﹤0.01% 388
2019
Q2 		$1.77M Hold
119,000
– – ﹤0.01% 383
2019
Q1 		$2.95M Hold
119,000
– – ﹤0.01% 375
2018
Q4 		$2.14M Hold
119,000
– – ﹤0.01% 371
2018
Q3 		$3.5M Buy
+119,000
New +$4.61M ﹤0.01% 370

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors's CLVS Position: Q3 2020 in Review

Capital International Investors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2020, closing a stake of 119,000 shares — an estimated $803K sold.

Capital International Investors first reported a position in CLVS in Q3 2018 and held it in 8 quarters. The position peaked at $3.5M in Q3 2018. 169 funds tracked by Wall St. Rank hold CLVS as of Q3 2020.

  • Capital International Investors reported no remaining Clovis Oncology, Inc. position as of Q3 2020 after selling out during the quarter.
  • Capital International Investors sold 119,000 Clovis Oncology, Inc. shares in Q3 2020, an estimated $803K.
  • Capital International Investors first reported a position in Clovis Oncology, Inc. in Q3 2018 and held it in 8 quarters.
  • Capital International Investors's Clovis Oncology, Inc. position peaked at $3.5M in Q3 2018.
  • 169 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2020.

Based on Capital International Investors's 13F filing for Q3 2020, filed 13 Nov 2020.